3 min read

A COVID-19 vaccine for older adults -- one of our most vulnerable populations

By Peter H. Diamandis on Aug 11, 2020

A successful COVID-19 vaccine will need to protect those who are 65 or older, one of our most vulnerable populations.

Topics: Entrepreneurship Finance Exponentials Exponential Organizations machine learning Business Models who not how Software as a service SaaS Machine Learning as a service MLaaS coronavirus COVID-19 vaccine covaxx
7 min read

New COVID-19 vaccines are flooding our feeds, but are any of them manufacturable at scale?

By Peter H. Diamandis on Aug 2, 2020

We’re bombarded every day with news about the latest miracle vaccine candidate: when it will be available, which vaccines have reached clinical trials, the stock market performance of the manufacturers, and so on.

Topics: Entrepreneurship Finance Exponentials Exponential Organizations machine learning Business Models who not how Software as a service SaaS AI as a service AIaaS Machine Learning as a service MLaaS
4 min read

The most powerful vaccine you haven’t heard about…

By Peter H. Diamandis on Jul 30, 2020

The race is on. Across the globe, researchers, scientists and CEOs are developing more than 160 vaccines, all taking aim at COVID-19.

Topics: Entrepreneurship Finance Exponentials Exponential Organizations machine learning Business Models who not how Software as a service SaaS AI as a service AIaaS Machine Learning as a service MLaaS
13 min read

Who Not How: Software Edition

By Peter H. Diamandis on Dec 29, 2020

In the age of COVID, how do you 10X your business? And more broadly, in the coming decade, how do you go from a linear ‘old-school’ company to an ‘Exponential Organization’? Today, there is a clear strategy…

Topics: Entrepreneurship Finance Exponentials Exponential Organizations machine learning Business Models who not how Software as a service SaaS AI as a service AIaaS Machine Learning as a service MLaaS